Discover hope and healing through Angela and Marleigh Cummins' powerful journey after losing Rodney to colorectal cancer. Learn how their partnership with the Colorectal Cancer Alliance turned grief into advocacy, raising awareness and fostering community support to take on colorectal cancer.
A proposed federal budget could cut $715 billion from Medicaid, leaving 8.6 million Americans without insurance. Learn how this impacts cancer prevention, early detection, and survival—and what you can do to help protect care access.
After a stage IV colorectal cancer diagnosis, Heather’s biomarker test revealed a critical mutation — opening the door to clinical trials and new hope.
The meetings are part of a broader government advocacy initiative by the Alliance to address the growing prevalence of CRC and improve patient care, advance research, and break down regulatory barriers that limit access to life-saving treatments.
A common method for educating a new administration about an organization’s cause — and sharing how the president can improve the situation for the American people — is through a document called a transition memo.
Discover how knowing her G12C biomarker guided Lexie’s stage IV colorectal cancer treatment — from a shock diagnosis to HIPEC surgery — and why screening, research, and self-advocacy matter.
Learn how triathlete and father Paul Weigel overcame stage III colorectal cancer, wrote "Iron Dad," and inspires early detection and candid GI discussions.
Uncover key survey findings on the unmet psychosocial and physical needs of colorectal cancer patients and survivors, and learn how the Alliance is shaping better care.
Allies shared their stories and the vital need to end colorectal cancer in this video presented at the national Blue Hope Bash in November 2024. The video features Bash co-chair and patient Alison Friedman.
The U.S. Food and Drug Administration has approved sotorasib in combination with panitumumab for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer.